XML 52 R33.htm IDEA: XBRL DOCUMENT v3.25.1
Restructuring (Tables)
3 Months Ended
Mar. 30, 2025
Restructuring and Related Activities [Abstract]  
Schedule of Restructuring Reserve
The following table summarizes the restructuring expenses for 2025 and 2024:
(Pre-tax Dollars in Millions)Q1 2025Q1 2024
MedTech Segment(1)
$5527
Innovative Medicine Segment(2)
0144
Total Programs$55171
(1)Includes $17 million in Restructuring, $8 million in Cost of products sold and $30 million in Other (Income)/Expense on the Consolidated Statement of Earnings in the fiscal first quarter of 2025. Included $20 million in Restructuring and $7 million in Cost of products sold on the Consolidated Statement of Earnings in the fiscal first quarter of 2024.
(2)Included in Restructuring on the Consolidated Statement of Earnings in the fiscal first quarter of 2024. This program was completed in the fiscal fourth quarter of 2024.